Analysis on whether afatinib (Gitaril) must be continued to be used once taken

Afatinib is an irreversible EGFRtyrosine kinase inhibitor, mainly used to treat EGFR mutation-positive advanced or metastatic non-small cell lung cancer. Because the drug prevents tumor cell proliferation by continuously inhibiting the EGFR signaling pathway, it is usually used daily orally for long-term use in treatment regimens. The efficacy of the drug depends on the continuous inhibition of tumor growth signals. If the drug is interrupted, the tumor may quickly resume proliferation, affecting the overall efficacy and disease control rate.

According toNCCN and the Chinese Lung Cancer Diagnosis and Treatment Guidelines, if afatinib is well tolerated by the patient and the disease is controllable, afatinib should be used continuously until the disease progresses or intolerable adverse reactions occur. Clinical trial data show that long-term continuous medication can significantly extend progression-free survival (PFS) and overall survival (OS). Therefore, once afatinib treatment is started, it is usually not recommended to stop or discontinue the treatment at will to ensure the best therapeutic effect.

Although continuous use is generally required, when severe side effects are encountered, such as rash, diarrhea, stomatitis or abnormal liver function, doctors may adjust the dosage or short-term discontinuation of the drug to alleviate the adverse reactions based on the patient's specific conditions. After the symptoms are controlled, the original dose can be restored or the dose can be reduced for maintenance treatment under the guidance of a doctor. This "temporary interruption-readjustment" strategy can balance drug efficacy and patient tolerance without affecting long-term treatment goals.

Patients should be reviewed regularly while taking afatinib, including imaging evaluation and liver and kidney function tests, to ensure disease control and monitor potential adverse reactions. Daily medication should be strictly followed as prescribed by your doctor, and you should not stop taking medication on your own or change the dosage at will. If you experience discomfort or plan to stop taking the drug for a short period of time, you should communicate with the attending doctor in time to formulate a reasonable adjustment plan to ensure continued effective treatment and reduce the risk of tumor recurrence.

Reference materials:https://www.drugs.com/